Alliance for Regenerative Medicine Announces CEO Transition
April 27, 2022
Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy organization for cell, gene and tissue-engineered therapies through five years of extraordinary growth in membership, funding, and influence.
Cell and Gene Therapies Poised to Disrupt Health Care Status Quo with Wave of New Treatments
March 31, 2022
The Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today released its 2021 Annual Report, showcasing a year of significant advances and forecasting continued growth ahead.
ARM Commends Reps. DeGette and Upton for the Release of ‘Cures 2.0’ Legislation
November 17, 2021
The bill will benefit patients by increasing the use of real-world evidence, incorporating patient experience data into regulatory reviews, and establishing guidance for CMC standards in expedited pathways. Together, these and other provisions of the bill will help our regulatory system keep pace with the groundbreaking advances of 21st Century science.